L-type calcium channel activation up-regulates the mRNAs for two different sodium channel alpha subunits (Nav1.2 and Nav1.3) in rat pituitary GH3 cells
- PMID: 12941467
- DOI: 10.1016/s0169-328x(03)00279-1
L-type calcium channel activation up-regulates the mRNAs for two different sodium channel alpha subunits (Nav1.2 and Nav1.3) in rat pituitary GH3 cells
Abstract
Calcium entry through L-type Ca2+ channels has been shown to increase the number of Na+ channels in GH3 cells, a clonal line of rat pituitary cells. To test whether this Ca2+ influx affects the levels of Na+ channel mRNAs, we first examined which Na+ channel subunits are expressed in GH3 cells. By using RT-PCR with specific primers, we detected transcripts for four alpha subunits (Nav1.1, Nav1.2, Nav1.3 and Nav1.6) and two auxiliary subunits (beta1 and beta3) of Na+ channels in total RNA from control GH3 cells. Next, we optimized the RT-PCR conditions to allow detection of cDNAs in the linear range of the assay. These conditions were then used to assess the transcript levels of Na+ channels after chronic exposure (72 h) of GH3 cells to the L-type Ca2+ channel blocker nimodipine (1 microM) or the L-type channel agonist Bay K 8644 (0.5 microM). Nimodipine treatment caused a moderate reduction (approximately 30%) of the mRNA for Nav1.2 and a marked reduction (approximately 70%) of the mRNA for Nav1.3, whereas treatment with Bay K 8644 produced 90-130% increases in these same mRNAs. There were no concomitant changes in the mRNAs for Nav1.1 and Nav1.6. Moreover, beta1 and beta3 mRNA levels were also unchanged. Thus, GH3 cells express multiple Na+ channel subunits and L-type Ca2+ channel activity up-regulates in a specific way the mRNAs for Nav1.2 and Nav1.3. These findings improve our knowledge on the molecular diversity of Na+ channels in pituitary cells and extend the actual view about the regulation of Na+ channel gene expression by Ca2+ influx.
Similar articles
-
L-type calcium channel activity regulates sodium channel levels in rat pituitary GH3 cells.J Physiol. 2000 Feb 15;523 Pt 1(Pt 1):45-55. doi: 10.1111/j.1469-7793.2000.00045.x. J Physiol. 2000. PMID: 10673544 Free PMC article.
-
Thyrotropin (TSH)-releasing hormone stimulates TSH beta promoter activity by two distinct mechanisms involving calcium influx through L type Ca2+ channels and protein kinase C.Mol Endocrinol. 1996 Jan;10(1):90-9. doi: 10.1210/mend.10.1.8838148. Mol Endocrinol. 1996. PMID: 8838148
-
Opposing actions of Bay K 8644 enantiomers on calcium current, prolactin secretion, and synthesis in pituitary cells.Mol Endocrinol. 1990 May;4(5):727-35. doi: 10.1210/mend-4-5-727. Mol Endocrinol. 1990. PMID: 1703274
-
The trafficking of Na(V)1.8.Neurosci Lett. 2010 Dec 10;486(2):78-83. doi: 10.1016/j.neulet.2010.08.074. Epub 2010 Sep 15. Neurosci Lett. 2010. PMID: 20816723 Free PMC article. Review.
-
Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?Curr Mol Pharmacol. 2015;8(2):110-22. doi: 10.2174/1874467208666150507105845. Curr Mol Pharmacol. 2015. PMID: 25966690 Free PMC article. Review.
Cited by
-
Characterization of Direct Perturbations on Voltage-Gated Sodium Current by Esaxerenone, a Nonsteroidal Mineralocorticoid Receptor Blocker.Biomedicines. 2021 May 13;9(5):549. doi: 10.3390/biomedicines9050549. Biomedicines. 2021. PMID: 34068333 Free PMC article.
-
Functional modulation of voltage-dependent sodium channel expression by wild type and mutated C121W-β1 subunit.J Bioenerg Biomembr. 2013 Aug;45(4):353-68. doi: 10.1007/s10863-013-9510-3. Epub 2013 Apr 13. J Bioenerg Biomembr. 2013. PMID: 23584539
-
Ion channels and signaling in the pituitary gland.Endocr Rev. 2010 Dec;31(6):845-915. doi: 10.1210/er.2010-0005. Epub 2010 Jul 21. Endocr Rev. 2010. PMID: 20650859 Free PMC article. Review.
-
Characterization in Potent Modulation on Voltage-Gated Na+ Current Exerted by Deltamethrin, a Pyrethroid Insecticide.Int J Mol Sci. 2022 Nov 25;23(23):14733. doi: 10.3390/ijms232314733. Int J Mol Sci. 2022. PMID: 36499059 Free PMC article.
-
The Evidence for Effective Inhibition of INa Produced by Mirogabalin ((1R,5S,6S)-6-(aminomethyl)-3-ethyl-bicyclo [3.2.0] hept-3-ene-6-acetic acid), a Known Blocker of CaV Channels.Int J Mol Sci. 2022 Mar 31;23(7):3845. doi: 10.3390/ijms23073845. Int J Mol Sci. 2022. PMID: 35409204 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous